193 related articles for article (PubMed ID: 21258884)
1. Immunoexpression of SALL4 in Wilms tumors and developing kidney.
Deisch J; Raisanen J; Rakheja D
Pathol Oncol Res; 2011 Sep; 17(3):639-44. PubMed ID: 21258884
[TBL] [Abstract][Full Text] [Related]
2. Glypican 3 overexpression in primary and metastatic Wilms tumors.
Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
[TBL] [Abstract][Full Text] [Related]
3. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
Yashima K; Maitra A; Timmons CF; Rogers BB; Pinar H; Shay JW; Gazdar AF
Hum Pathol; 1998 May; 29(5):536-42. PubMed ID: 9596280
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of neural cell adhesion molecule in Wilms tumors, nephrogenic rests, and fetal and postnatal renal cortices.
Kapur P; Rakheja D
Pediatr Dev Pathol; 2011; 14(1):16-9. PubMed ID: 20524836
[TBL] [Abstract][Full Text] [Related]
5. CITED1 expression in Wilms' tumor and embryonic kidney.
Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
[TBL] [Abstract][Full Text] [Related]
6. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours.
Ramani P; Cowell JK
J Pathol; 1996 Jun; 179(2):162-8. PubMed ID: 8758208
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
8. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
Murphy AJ; Pierce J; de Caestecker C; Libes J; Neblett D; de Caestecker M; Perantoni AO; Tanigawa S; Anderson JR; Dome JS; Das A; Carroll TJ; Lovvorn HN
Pediatr Blood Cancer; 2014 Feb; 61(2):198-205. PubMed ID: 24115727
[TBL] [Abstract][Full Text] [Related]
9. Expression of CCN3 protein in human Wilms' tumors: immunohistochemical detection of CCN3 variants using domain-specific antibodies.
Subramaniam MM; Lazar N; Navarro S; Perbal B; Llombart-Bosch A
Virchows Arch; 2008 Jan; 452(1):33-9. PubMed ID: 18066593
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a monoclonal antibody recognizing the blastemal element of Wilms' tumors and fetal kidneys.
Tarnowski BI; Hazen-Martin DJ; Garvin AJ; Sens MA; Sens DA
Pediatr Pathol; 1994; 14(5):849-62. PubMed ID: 7808983
[TBL] [Abstract][Full Text] [Related]
11. Metanephric adenoma, nephrogenic rests, and Wilms' tumor: a histologic and immunophenotypic comparison.
Muir TE; Cheville JC; Lager DJ
Am J Surg Pathol; 2001 Oct; 25(10):1290-6. PubMed ID: 11688464
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic rests, nephroblastomatosis, and associated lesions of the kidney.
Lonergan GJ; Martínez-León MI; Agrons GA; Montemarano H; Suarez ES
Radiographics; 1998; 18(4):947-68. PubMed ID: 9672980
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
14. Pan-cytokeratin immunoexpression in Wilms' tumors: a simple approach for understanding tumor epithelial differentiation.
Sredni ST; Neves JI; de Camargo B; Caballero OL; Soares FA
Sao Paulo Med J; 2004 Jul; 122(4):181-3. PubMed ID: 15543376
[TBL] [Abstract][Full Text] [Related]
15. Embryonal Origin of Metanephric Adenoma and its Differential Diagnosis.
Sarlos DP; Banyai D; Peterfi L; Szanto A; Kovacs G
Anticancer Res; 2018 Dec; 38(12):6663-6667. PubMed ID: 30504374
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
17. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
[TBL] [Abstract][Full Text] [Related]
18. Renal pathology in WAGR syndrome.
Ariel I; Abeliovich D; Bar-ziv J; Hochberg A
Pediatr Pathol Lab Med; 1996; 16(6):1013-21. PubMed ID: 9025899
[TBL] [Abstract][Full Text] [Related]
19. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
[TBL] [Abstract][Full Text] [Related]
20. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.
Sandberg JK; Chi YY; Smith EA; Servaes S; Hoffer FA; Mullen EA; Perlman EJ; Tornwall B; Ehrlich PF; Geller JI; Grundy PE; Fernandez CV; Dome JS; Khanna G
AJR Am J Roentgenol; 2020 May; 214(5):987-994. PubMed ID: 32160052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
